Legal Disclaimer
This page provides general legal orientation for Massachusetts, not legal advice. Peptide regulations change frequently. Always verify current statutes with your state pharmacy board and consult a licensed attorney for specific legal guidance.
Peptide Legal Status in Massachusetts
Enhanced state-level restrictions on compounding and distribution. Massachusetts enacted some of the nation's strictest compounding pharmacy laws following the 2012 NECC meningitis outbreak. The state requires enhanced testing, reporting, and oversight for all compounded preparations.
Want provider rollout updates for Massachusetts?
We are expanding country-aware provider workflows beyond the US. Join the rollout list for Massachusetts-adjacent legal and provider guidance.
Join provider rolloutKey Facts
Massachusetts Regulatory Details
Peptide Availability in Massachusetts
| Peptide | FDA Status | Evidence | Availability |
|---|---|---|---|
| BPC-157 | Not Approved | C | Restricted |
| TB-500 (Thymosin Beta-4) | Not Approved | C | Restricted |
| GHK-Cu | Not Approved | B | Restricted |
| Ipamorelin | Not Approved | B | Restricted |
| CJC-1295 | Not Approved | B | Restricted |
| Sermorelin | Approved | A | Available by Rx |
| Tesamorelin | Approved | A | Available by Rx |
| Bremelanotide (PT-141) | Approved | A | Available by Rx |
| Semaglutide | Approved | A | Available by Rx |
| Tirzepatide | Approved | A | Available by Rx |
| AOD-9604 | Not Approved | C | Restricted |
| DSIP (Delta Sleep-Inducing Peptide) | Not Approved | D | Restricted |
| Epithalon (Epitalon) | Not Approved | C | Restricted |
| Selank | Not Approved | B | Restricted |
| Semax | Not Approved | B | Restricted |
| GHRP-2 | Not Approved | B | Restricted |
| GHRP-6 | Not Approved | B | Restricted |
| Hexarelin | Not Approved | B | Restricted |
| Melanotan II | Not Approved | C | Restricted |
| LL-37 | Not Approved | C | Restricted |
| Thymalin | Not Approved | C | Restricted |
| KPV | Not Approved | D | Restricted |
| Liraglutide | Approved | A | Available by Rx |
| Retatrutide | Not Approved | B | Restricted |
| Exenatide | Approved | A | Available by Rx |
| Dulaglutide | Approved | A | Available by Rx |
| Teriparatide | Approved | A | Available by Rx |
| Octreotide | Approved | A | Available by Rx |
| Triptorelin | Approved | A | Available by Rx |
| Desmopressin | Approved | A | Available by Rx |
| Setmelanotide | Approved | A | Available by Rx |
| Pramlintide | Not Approved | A | Restricted |
| Survodutide | Not Approved | B | Restricted |
| Linaclotide | Approved | A | Available by Rx |
| Plecanatide | Approved | A | Available by Rx |
| Teduglutide | Approved | A | Available by Rx |
| Abaloparatide | Approved | A | Available by Rx |
| Lanreotide | Approved | A | Available by Rx |
| Ziconotide | Approved | A | Available by Rx |
| Vosoritide | Approved | A | Available by Rx |
| SS-31 (Elamipretide) | Not Approved | B | Restricted |
| MOTS-c | Not Approved | C | Restricted |
| Humanin | Not Approved | C | Restricted |
| FOXO4-DRI | Not Approved | D | Restricted |
| Cerebrolysin | Not Approved | B | Restricted |
| Oxytocin | Approved | A | Available by Rx |
| Dihexa | Not Approved | D | Restricted |
| IGF-1 LR3 | Not Approved | D | Restricted |
| Follistatin-344 | Not Approved | D | Restricted |
| MGF (Mechano Growth Factor) | Not Approved | D | Restricted |
| P21 | Not Approved | D | Restricted |
| Kisspeptin-10 | Not Approved | B | Restricted |
| Gonadorelin (GnRH) | Approved | A | Available by Rx |
| ARA-290 (Cibinetide) | Not Approved | B | Restricted |
| Adamax | Not Approved | D | Restricted |
| Pinealon | Not Approved | C | Restricted |
| Tesofensine | Not Approved | A | Restricted |
Peptides in Massachusetts: FAQ
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.